Medtronic (MDT) terminates deal to acquire EOFlow

Medtronic (NYSE: MDT) said on December 6, 2023, based upon multiple breaches under the Agreements, it delivered notice to EOFlow that it had exercised its right to terminate the Agreements. Medtronic does not believe any termination fee is payable under the Agreements. The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.

You May Also Be Interested In

• Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
• Curaleaf launches hostile takeover bid for Aurora Cannabis at $4/share
• EXL closes $1 billion credit facility, up from $600 million